Bellevue Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.4M | Sell |
52,518
-17,127
| -25% | -$5.63M | 0.37% | 56 |
|
|
2025
Q4 | $24.4M | Sell |
69,645
-35,326
| -34% | -$11.9M | 0.46% | 45 |
|
|
2025
Q3 | $33.9M | Buy |
104,971
+22,918
| +28% | +$7.13M | 0.7% | 35 |
|
|
2025
Q2 | $31.9M | Buy |
82,053
+41,995
| +105% | +$16.9M | 0.7% | 36 |
|
|
2025
Q1 | $17.4M | Buy |
40,058
+1,715
| +4% | +$688K | 0.39% | 55 |
|
|
2024
Q4 | $14.1M | Sell |
38,343
-50,985
| -57% | -$21.3M | 0.27% | 71 |
|
|
2024
Q3 | $46.5M | Sell |
89,328
-12,221
| -12% | -$6.53M | 0.75% | 36 |
|
|
2024
Q2 | $55M | Buy |
101,549
+2,937
| +3% | +$1.55M | 0.89% | 27 |
|
|
2024
Q1 | $51.1M | Sell |
98,612
-9,176
| -9% | -$4.56M | 0.78% | 35 |
|
|
2023
Q4 | $50.8M | Sell |
107,788
-66,099
| -38% | -$30.6M | 0.78% | 40 |
|
|
2023
Q3 | $75.7M | Buy |
173,887
+71,434
| +70% | +$32.4M | 1.22% | 22 |
|
|
2023
Q2 | $45.5M | Buy |
102,453
+9,483
| +10% | +$4.37M | 0.65% | 51 |
|
|
2023
Q1 | $42.7M | Sell |
92,970
-56,451
| -38% | -$26.9M | 0.62% | 51 |
|
|
2022
Q4 | $76.6M | Sell |
149,421
-53,071
| -26% | -$26.9M | 1.02% | 30 |
|
|
2022
Q3 | $92M | Sell |
202,492
-6,008
| -3% | -$2.87M | 1.32% | 23 |
|
|
2022
Q2 | $101M | Sell |
208,500
-203,137
| -49% | -$100M | 1.42% | 15 |
|
|
2022
Q1 | $202M | Sell |
411,637
-43,657
| -10% | -$20M | 2.35% | 8 |
|
|
2021
Q4 | $211M | Sell |
455,294
-19,916
| -4% | -$8.38M | 2.18% | 10 |
|
|
2021
Q3 | $177M | Buy |
475,210
+9,234
| +2% | +$3.51M | 1.8% | 13 |
|
|
2021
Q2 | $178M | Buy |
465,976
+80,428
| +21% | +$30.7M | 1.74% | 13 |
|
|
2021
Q1 | $138M | Buy |
385,548
+49,755
| +15% | +$16M | 1.46% | 16 |
|
|
2020
Q4 | $108M | Sell |
335,793
-13,330
| -4% | -$4.09M | 1.23% | 26 |
|
|
2020
Q3 | $93.8M | Buy |
349,123
+39,098
| +13% | +$10.5M | 1.3% | 21 |
|
|
2020
Q2 | $81.5M | Sell |
310,025
-55,578
| -15% | -$14.8M | 1.15% | 24 |
|
|
2020
Q1 | $83M | Buy |
365,603
+40,429
| +12% | +$11M | 1.61% | 16 |
|
|
2019
Q4 | $98.2M | Buy |
325,174
+19,068
| +6% | +$5.25M | 1.56% | 15 |
|
|
2019
Q3 | $73.5M | Sell |
306,106
-54,633
| -15% | -$15M | 1.37% | 20 |
|
|
2019
Q2 | $102M | Buy |
360,739
+105,722
| +41% | +$28.9M | 1.74% | 14 |
|
|
2019
Q1 | $73.2M | Buy |
255,017
+22,357
| +10% | +$6.47M | 4.03% | 6 |
|
|
2018
Q4 | $61.1M | Buy |
232,660
+8,472
| +4% | +$2.33M | 4.02% | 6 |
|
|
2018
Q3 | $61.4M | Buy |
224,188
+10,661
| +5% | +$2.77M | 3.9% | 1 |
|
|
2018
Q2 | $50.8M | Buy |
213,527
+32,284
| +18% | +$7.48M | 4.33% | 1 |
|
|
2018
Q1 | $39.8M | Hold |
181,243
| – | – | 3.94% | 2 |
|
|
2017
Q4 | $40.8M | Buy |
181,243
+10,100
| +6% | +$2.15M | 4.26% | 2 |
|
|
2017
Q3 | $32.5M | Buy |
171,143
+47,796
| +39% | +$9.1M | 3.4% | 6 |
|
|
2017
Q2 | $23.2M | Buy |
123,347
+12,887
| +12% | +$2.32M | 2.74% | 5 |
|
|
2017
Q1 | $18.3M | Buy |
110,460
+89,860
| +436% | +$14.3M | 2.43% | 8 |
|
|
2016
Q4 | $2.96M | Hold |
20,600
| – | – | 0.61% | 47 |
|
|
2016
Q3 | $2.58M | Buy |
20,600
+6,600
| +47% | +$852K | 0.47% | 59 |
|
|
2016
Q2 | $1.84M | Sell |
14,000
-16,000
| -53% | -$2.19M | 0.35% | 75 |
|
|
2016
Q1 | $4.17M | Buy |
+30,000
| New | +$4.01M | 0.76% | 46 |
|
Other funds holding ELV
VCM
VPM
Bellevue Group's ELV Position: Q1 2026 in Review
Bellevue Group reduced its Elevance Health (ELV) stake by 25% in Q1 2026, selling an estimated $5.63M and leaving 52,518 shares worth $15.4M. The position accounts for 0.37% of the portfolio, ranked #56.
Bellevue Group first reported a position in ELV in Q1 2016 and has held it in 41 quarters since. The position peaked at $211M in Q4 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Bellevue Group held 52,518 shares of Elevance Health worth $15.4M as of Q1 2026.
- Bellevue Group sold 17,127 Elevance Health shares in Q1 2026, an estimated $5.63M.
- Elevance Health made up 0.37% of Bellevue Group's portfolio in Q1 2026, its #56 holding.
- Bellevue Group first reported a position in Elevance Health in Q1 2016 and has held it in 41 quarters since.
- Bellevue Group's Elevance Health position peaked at $211M in Q4 2021.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.